annual CFI:
-$2.01B-$1.23B(-159.36%)Summary
- As of today (June 28, 2025), PCVX annual cash flow from investing activities is -$2.01 billion, with the most recent change of -$1.23 billion (-159.36%) on December 31, 2024.
- During the last 3 years, PCVX annual CFI has fallen by -$1.79 billion (-844.70%).
- PCVX annual CFI is now -2789.10% below its all-time high of $74.58 million, reached on December 31, 2022.
Performance
PCVX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$123.32M+$680.49M(+122.13%)Summary
- As of today (June 28, 2025), PCVX quarterly cash flow from investing activities is $123.32 million, with the most recent change of +$680.49 million (+122.13%) on March 31, 2025.
- Over the past year, PCVX quarterly CFI has increased by +$574.39 million (+127.34%).
- PCVX quarterly CFI is now at all-time high.
Performance
PCVX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$1.43B+$574.39M(+28.64%)Summary
- As of today (June 28, 2025), PCVX TTM cash flow from investing activities is -$1.43 billion, with the most recent change of +$574.39 million (+28.64%) on March 31, 2025.
- Over the past year, PCVX TTM CFI has dropped by -$654.99 million (-84.38%).
- PCVX TTM CFI is now -1393.88% below its all-time high of $110.62 million, reached on September 30, 2022.
Performance
PCVX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PCVX Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -159.4% | +127.3% | -84.4% |
3 y3 years | -844.7% | +148.3% | -10000.0% |
5 y5 years | -10000.0% | +10000.0% | -10000.0% |
PCVX Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -2789.1% | at low | at high | +113.5% | -1393.9% | +28.6% |
5 y | 5-year | -2789.1% | at low | at high | +113.5% | -1393.9% | +28.6% |
alltime | all time | -2789.1% | at low | at high | +113.5% | -1393.9% | +28.6% |
PCVX Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $123.32M(-122.1%) | -$1.43B(-28.6%) |
Dec 2024 | -$2.01B(+159.4%) | -$557.17M(-39.2%) | -$2.01B(+37.1%) |
Sep 2024 | - | -$917.02M(+1040.5%) | -$1.46B(+179.6%) |
Jun 2024 | - | -$80.41M(-82.2%) | -$523.13M(-32.6%) |
Mar 2024 | - | -$451.07M(+3139.1%) | -$776.28M(+0.4%) |
Dec 2023 | -$773.31M(-1136.8%) | -$13.93M(-162.5%) | -$773.31M(-2.8%) |
Sep 2023 | - | $22.28M(-106.7%) | -$795.34M(+1.6%) |
Jun 2023 | - | -$333.56M(-25.6%) | -$782.91M(+85.0%) |
Mar 2023 | - | -$448.10M(+1146.4%) | -$423.18M(-667.4%) |
Dec 2022 | $74.58M(-135.1%) | -$35.95M(-203.6%) | $74.58M(-32.6%) |
Sep 2022 | - | $34.71M(+32.6%) | $110.62M(+92.6%) |
Jun 2022 | - | $26.16M(-47.3%) | $57.44M(+434.4%) |
Mar 2022 | - | $49.67M(>+9900.0%) | $10.75M(-105.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$212.31M(>+9900.0%) | $82.00K(-100.4%) | -$212.31M(-0.4%) |
Sep 2021 | - | -$18.47M(-10.0%) | -$213.11M(+9.5%) |
Jun 2021 | - | -$20.53M(-88.2%) | -$194.62M(+11.8%) |
Mar 2021 | - | -$173.39M(>+9900.0%) | -$174.15M(>+9900.0%) |
Dec 2020 | -$1.10M(-7.5%) | -$722.00K(-3538.1%) | -$1.10M(-17.3%) |
Sep 2020 | - | $21.00K(-138.2%) | -$1.34M(-5.7%) |
Jun 2020 | - | -$55.00K(-84.2%) | -$1.42M(-7.3%) |
Mar 2020 | - | -$349.00K(-63.4%) | -$1.53M(+27.9%) |
Dec 2019 | -$1.20M(-32.6%) | -$953.00K(+1488.3%) | -$1.20M(+393.8%) |
Sep 2019 | - | -$60.00K(-63.9%) | -$242.00K(+33.0%) |
Jun 2019 | - | -$166.00K(+937.5%) | -$182.00K(+1037.5%) |
Mar 2019 | - | -$16.00K | -$16.00K |
Dec 2018 | -$1.77M | - | - |
FAQ
- What is Vaxcyte annual cash flow from investing activities?
- What is the all time high annual CFI for Vaxcyte?
- What is Vaxcyte annual CFI year-on-year change?
- What is Vaxcyte quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Vaxcyte?
- What is Vaxcyte quarterly CFI year-on-year change?
- What is Vaxcyte TTM cash flow from investing activities?
- What is the all time high TTM CFI for Vaxcyte?
- What is Vaxcyte TTM CFI year-on-year change?
What is Vaxcyte annual cash flow from investing activities?
The current annual CFI of PCVX is -$2.01B
What is the all time high annual CFI for Vaxcyte?
Vaxcyte all-time high annual cash flow from investing activities is $74.58M
What is Vaxcyte annual CFI year-on-year change?
Over the past year, PCVX annual cash flow from investing activities has changed by -$1.23B (-159.36%)
What is Vaxcyte quarterly cash flow from investing activities?
The current quarterly CFI of PCVX is $123.32M
What is the all time high quarterly CFI for Vaxcyte?
Vaxcyte all-time high quarterly cash flow from investing activities is $123.32M
What is Vaxcyte quarterly CFI year-on-year change?
Over the past year, PCVX quarterly cash flow from investing activities has changed by +$574.39M (+127.34%)
What is Vaxcyte TTM cash flow from investing activities?
The current TTM CFI of PCVX is -$1.43B
What is the all time high TTM CFI for Vaxcyte?
Vaxcyte all-time high TTM cash flow from investing activities is $110.62M
What is Vaxcyte TTM CFI year-on-year change?
Over the past year, PCVX TTM cash flow from investing activities has changed by -$654.99M (-84.38%)